Stock ownership · SEC 13F · Q4 2025
VERTEX PHARMACEUTICALS I
Who owns VERTEX PHARMACEUTICALS I (CUSIP 92532F100)? A look at the institutions behind it, how tightly they hold it, and the latest quarter's moves.
- $109.7M
- Reported value
- 11
- Institutions
- 100%
- Top-5 share
The verdict
According to SEC Form 13F-HR filings in this corpus, VERTEX PHARMACEUTICALS I ranks #120 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders. 11 institutions report $109.7M as of Q4 2025, with ownership dominated by its top few institutional owners.
- 11
- institutions hold it
- $109.7M
- reported 13F value
- 100%
- held by top 5
- #120
- of 775 by value
Based on long positions reported to the SEC as of Q4 2025; 13F omits shorts, options and non-US holdings.
According to SEC Form 13F-HR filings in this corpus, VERTEX PHARMACEUTICALS I ranks #120 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders.
How 13F ownership is computed · All tracked stocks · Concentration rankings
SEC Form 13F-HR ownership desk
CUSIP 92532F100 · Q4 2025 $110M reported
VALUE-HEAVY · HOLDERS-NARROW · CONC-DOM · PHOTO-FINISH · ACTIVITY-QUIET · BOOK-FULL
- VALUE-HEAVY #120/775
- HOLDERS-NARROW 11 filers
- CONC-DOM 100% top-5
- PHOTO-FINISH AMERICAN EXPRESS
- ACTIVITY-QUIET 0 new
- BOOK-FULL 8Q history
Photo-finish peer on reported value: AMERICAN EXPRESS CO
Read with: Ownership concentration guide - VERTEX PHARMACEUTICALS I's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.
Reported-value neighbourhood · VERTEX PHARMACEUTICALS I
Nearest tracked securities by aggregate 13F reported value, not a full corpus reprint.
VERTEX PHARMACEUTICALS I vs. the broadly-held institutional universe
Where this security's reporting-institution count sits among tracked 13F securities
11 Top 67% higher than 33% of 216 securities
Broadly-held tracked securities, banded by reporting-institution count
Each bar is a band; taller bars hold more securities. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source SEC Form 13F-HR filings · Q4 2025
Institutional ownership over time
The number of institutions reporting a VERTEX PHARMACEUTICALS I position has risen from 8 to 11 over the last 8 quarters of 13F filings.
Top Institutional Holders
| # | Institution | Shares | Value | Share of reported |
|---|---|---|---|---|
| 1 | GROUPAMA ASSET MANAGMENT | 163,144 | $74.0M | 67.4% |
| 2 | Pacer Advisors, Inc. | 76,142 | $34.5M | 31.5% |
| 3 | DGS Capital Management, LLC | 1,161 | $526K | 0.5% |
| 4 | Banque Transatlantique SA | 539 | $244K | 0.2% |
| 5 | Anchor Investment Management, LLC | 495 | $224K | 0.2% |
| 6 | CHELSEA COUNSEL CO | 150 | $68K | 0.1% |
| 7 | Bell Investment Advisors, Inc | 132 | $60K | 0.1% |
| 8 | MidFirst Bank | 131 | $59K | 0.1% |
| 9 | TD Capital Management LLC | 75 | $34K | 0.0% |
| 10 | Strategic Investment Solutions, Inc. /IL | 38 | $17K | 0.0% |
| 11 | SG Trading Solutions, LLC | 544 | $247 | 0.0% |
Investment Discretion
SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among VERTEX PHARMACEUTICALS I's reported holders for Q4 2025, by reported value:
Latest Quarter Activity · Q4 2025
Frequently Asked Questions
How many institutions hold VERTEX PHARMACEUTICALS I?▼
Where does VERTEX PHARMACEUTICALS I sit among tracked securities?▼
What is the total institutional value of VERTEX PHARMACEUTICALS I?▼
How concentrated is ownership of VERTEX PHARMACEUTICALS I?▼
Who is the largest institutional holder of VERTEX PHARMACEUTICALS I?▼
Nationwide stocks with similar institutional value or holder count
Two 13F-derived peer sets for VERTEX PHARMACEUTICALS I: nearest aggregate reported value and nearest institutional holder count, not catalog browse links.
Similar reported value
Nearest stocks by aggregate 13F reported value ($109.7M here).
Similar holder count
Nearest stocks by number of disclosing 13F holders (11 here).
Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.
PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-09-26.